N. Vu-dac

发表

Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans*

Jean Dubuisson, K. Gustafson, C. Voisset, 2006, Journal of Biological Chemistry.

High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I*

Jean Dubuisson, E. Blanchard, C. Voisset, 2005, Journal of Biological Chemistry.

Characterization of a monoclonal antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apo E. Applications to ELISA quantification of plasma apo E.

J. Fruchart, V. Clavey, N. Vu-dac, 1988, Journal of immunoassay.

Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.

J. Auwerx, K. Schoonjans, B. Staels, 1994, The Journal of biological chemistry.

Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators*

L. Pennacchio, E. Rubin, B. Staels, 2003, The Journal of Biological Chemistry.

The increased plasma Lp(a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis.

M. Alessi, J. Fruchart, P. Joly, 1990, Clinica chimica acta; international journal of clinical chemistry.

Expression, location and cross-reactivity of two antigenic sites on the amino terminal region of rabbit and human apolipoprotein A-I.

F. Pio, J. Fruchart, N. Théret, 1989, Atherosclerosis.

Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-I.

N. Vu-dac, A. Leroy, J. Fruchart, 1989, Clinica chimica acta; international journal of clinical chemistry.

Standardization of an Enzymometric Assay for Apolipoprotein A-I by Using Mixtures of Monoclonal Antibodies

N. Vu-dac, H. Mezdour, A. C. Nestruck, 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Latex immunoassay of human serum Lp(a+) lipoprotein.

J. Fruchart, P. Duthilleul, N. Vu-dac, 1985, Journal of lipid research.

Evidence for an interaction of lipoprotein lipase with artery wall proteoglycans.

N. Vu-dac, J. Picard, J. Gardette, 1989, The International journal of biochemistry.

3P-0816∗ Apolipoprotein A5 is an inflammatory responsive gene down-regulated by tumor necrosis factorα and interleukin-1

L. Pennacchio, E. Rubin, J. Fruchart, 2003 .

Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.

T. Kooistra, J. Dallongeville, B. Staels, 1998, The Journal of clinical investigation.

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

J. Auwerx, J. Dallongeville, B. Staels, 1995, The Journal of clinical investigation.

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

J. Auwerx, J. Dallongeville, K. Schoonjans, 1995, The Journal of clinical investigation.

The Orphan Nuclear Receptor Rev-Erbα Is a Peroxisome Proliferator-activated Receptor (PPAR) γ Target Gene and Promotes PPARγ-induced Adipocyte Differentiation*

S. Mandrup, F. Soncin, C. Fontaine, 2003, Journal of Biological Chemistry.

Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.

J. Auwerx, B. Staels, J. Fruchart, 1996, European journal of biochemistry.

Transcriptional Regulation of Apolipoprotein A-I Gene Expression by the Nuclear Receptor RORα*

J. Auwerx, J. Mariani, K. Schoonjans, 1997, The Journal of Biological Chemistry.

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry

C. Voisset, J. Dubuisson, C. Wychowski, 2008, Cellular microbiology.

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

C. Voisset, J. Dubuisson, G. Duverlie, 2006, Hepatology.

High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI*

Ralf Bartenschlager, Sylvie Ricard-Blum, Jean Dubuisson, 2006, Journal of Biological Chemistry.

The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates*

V. Laudet, B. Staels, J. Fruchart, 1998, The Journal of Biological Chemistry.

Basic Residues in Hypervariable Region 1 of Hepatitis C Virus Envelope Glycoprotein E2 Contribute to Virus Entry

F. Penin, J. Pawlotsky, B. Bartosch, 2005, Journal of Virology.

The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation.

S. Mandrup, F. Soncin, C. Fontaine, 2003, The Journal of biological chemistry.

Purification of human apolipoprotein A-IV by fast protein liquid chromatography.

V. Clavey, N. Vu-dac, H. Kaffarnik, 1989, Journal of chromatography.

Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor

J. Auwerx, J. Dallongeville, K. Schoonjans, 1996, Molecular and cellular biology.

Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β*

Robert Kleemann, Teake Kooistra, T. Kooistra, 2001, The Journal of Biological Chemistry.

High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.

C. Voisset, J. Dubuisson, F. Cosset, 2006, The Journal of general virology.

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.

B Staels, T. Kooistra, R. Kleemann, 2001, The Journal of biological chemistry.

Identification of a second promoter in the human c-ets-2 proto-oncogene.

V. Laudet, P. Crépieux, D. Stéhelin, 1997, Gene expression.